Stocks / NASDAQ / Endocyte, Inc.

Endocyte, Inc.

Our Opinion

Endocyte, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products and clinical research.

Supporting Evidence:

The company stated in its drug-development process that they conduct pre-clinical trials of their drugs on animals.

“The companion imaging agent enables testing in preclinical animal models and humans to find out whether the SMDC targets the diseased cells and not normal cells.” Read the full article.

Company Description

Endocyte, Inc. is a biopharmaceutical company, which engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are active target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. [Source: MarketWatch]

Company Website: